Article Text

Download PDFPDF
Intraocular pressure and visual outcomes following intracameral triamcinolone assisted anterior vitrectomy in complicated cataract surgery
  1. R I Angunawela,
  2. S E Liyanage,
  3. S C Wong,
  4. B C Little
  1. Department of Ophthalmology, Royal Free Hospital, London, Pond Street, London, UK
  1. Correspondence to Mr R I Angunawela, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK; romeshi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Vitreous loss during phacoemulsification is relatively common (1–7%).1 Burk et al described the use of intracameral triamcinalone acetonide (TA) for staining vitreous during anterior vitrectomy (AV) in 2003.1 We have routinely used this technique for a number of years.

Triamcinolone has a long history of intraocular use.2 3 A number of reports suggest an increased risk of ocular hypertension/glaucoma after intravitreal use.4

There is a lack of clinical outcome data after TA-aided AV. Here, we report the 3-month outcomes of intraocular pressure (IOP) and visual acuity (VA) in 14 patients with posterior capsular rupture, vitreous loss and triamcinalone-aided AV.


Data were collected over 18 months. Patients who had TA-assisted AV were identified, and VAs and IOP were recorded at 1 day, 1 month and 3 months after surgery. No patients had previous ocular hypertension or …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.